|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013显示文摘 | Michele Baccarani Michael W. Deininger Gianantonio Rosti Andreas Hochhaus Simona Soverini Jane F. Apperley Francisco Cervantes Richard E. Clark Jorge E. Cortes Fran?ois Guilhot Henrik Hjorth-Hansen Timothy P. Hughes Hagop M. Kantarjian Dong-Wook Kim Richa | 2013 | Blood2013，，6： | 3 |
| 2 | WRKY72‐type transcription factors contribute to basal immunity in tomato and Arabidopsis as well as gene‐for‐gene resistance mediated by the tomato R?gene Mi‐1显示文摘 | Kishor K.Bhattarai Hagop S.Atamian IsgouhiKaloshian ThomasEulgem | 2010 | The Plant Journal2010，，： | 2 |
| 3 | Nilotinib in imatinib-resistant CML and philadelphia chromosome-positive aLL显示文摘 | Hagop Kantarjian Francis Giles Lydia Wunderle | 2006 | N Engl J Med2006，354，： | 1 |
| 4 | The prognostic significance of p16INK4a/p14ARF locus deletion and MDM‐2 protein expression in adult acute myelogenous leukemia显示文摘 | StefanFaderl Hagop M.Kantarjian ElihuEstey TaghiManshouri Ching‐YangChan AbdelRahman Elsaied Steven M.Kornblau JorgeCortes Deborah A.Thomas SherryPierce Michael J.Keating ZeevEstrov MaherAlbitar | 2000 | Cancer2000，，： | 1 |
| 5 | A pilot study of inteleukin-2 for adult patients with acute myelogenous leukemia in first complete remission显示文摘 | Hagop MK Susan OB | 1999 | Cancer1999，85，： | 1 |
| 6 | TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament显示文摘 | Hagop S. Akiskal Mauro V. Mendlowicz Girardin Jean-Louis Mark H. Rapaport John R. Kelsoe J.Christian Gillin Tom L. Smith | 2003 | Journal of Affective Disorders2003，，1： | 1 |
| 7 | ATM gene deletion in patients with adult acute lymphoblastie leukemia显示文摘 | Mohammad A Hagop K Taghi M | 2000 | Cancer2000，88，5： | 1 |
| 8 | Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes显示文摘 | Alvaro A Hagop K Taghi M | 2000 | Blood2000，1596，6： | 1 |
| 9 | Bipolar pharmacotherapy and suicidal behavior显示文摘 | Boghos I. Yerevanian Ralph J. Koek Jim Mintz Hagop S. Akiskal | 2007 | Journal of Affective Disorders2007，，： | 1 |
| 10 | Epigenetics of Acute Lymphocytic Leukemia显示文摘 | Guillermo Garcia-Manero Hui Yang Shao-Qing Kuang Susan O’Brien Deborah Thomas Hagop Kantarjian | 2009 | Seminars in Hematology2009，，1： | 1 |
| 11 | Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management显示文摘 | Elias Jabbour Hagop Kantarjian | 2012 | Am J Hematol2012，，11： | 1 |
| 12 | Apoptosis repressor with caspase recruitment domain modulates second mitochondrial‐derived activator of caspases mimetic‐induced cell death through BIRC 2/ MAP 3K14 signalling in acute myeloid leukaemia显示文摘 | Po Y. Mak Duncan H. Mak Vivian Ruvolo Rodrigo Jacamo Steven M. Kornblau Hagop Kantarjian Michael Andreeff Bing Z. Carter | 2014 | Br J Haematol2014，，： | 1 |
| 13 | Temperament profiles in physicians, lawyers, managers, industrialists, architects, journalists, and artists: a study in psychiatric outpatients显示文摘 | Kareen K. Akiskal Mario Savino Hagop S. Akiskal | 2004 | Journal of Affective Disorders2004，，1： | 1 |
| 14 | Expression of constitutively active Nuclear-κB RelA transcription factor in blasts of acute myeloid leukemia显示文摘 | Carlos E Bueso-Ramos Frederico C Rocha Shishir Shishodia L.Jeffrey Medeiros Hagop M Kantarjian Saroj Vadhan-Raj Zeev Estrov Terry L Smith Martin H Nguyen Bharat B Aggarwal | 2004 | Human Pathology2004，，2： | 1 |
| 15 | Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting 显示文摘 | Razelle Kurzrock Hagop MK Jorge EC | 2003 | Blood2003，102，13： | 1 |
| 16 | Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial显示文摘 | Hagop M Kantarjian Andreas Hochhaus Giuseppe Saglio Carmino De Souza Ian W Flinn Leif Stenke Yeow-Tee Goh Gianantonio Rosti Hirohisa Nakamae Neil J Gallagher Albert Hoenekopp Rick E Blakesley Richard A Larson Timothy P Hughes | 2011 | Lancet Oncology2011，，9： | 1 |
| 17 | Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome 显示文摘 | Hagop M Kantarjian MD Susan O'Brien | 2007 | Cancer2007，109，2： | 1 |
| 18 | Use of arsenictrioxide (AS2O3) in the treatment of patients with acute promyelocyticleukemia显示文摘 | Gullermo L M D Hagop K M D Elihu E M D | 2003 | Cancer2003，97，9： | 1 |
| 19 | A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma显示文摘 | Andrew Ko Hagop Youssoufian Jayne Gurtler Karel Dicke Omar Kayaleh Heinz-Josef Lenz Mark Keaton Terry Katz Shaila Ballal Eric Rowinsky | 2012 | Investigational New Drugs2012，，4： | 1 |
| 20 | Low-dose decitabine and high-risk MDS 显示文摘 | Hagop MK Yasuhiro O Jean-Pierre I | 2006 | Blood2006，108，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员